Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patients

被引:26
|
作者
Jouinot, Anne [1 ,2 ,3 ,4 ]
Ulmann, Guillaume [5 ,6 ]
Vazeille, Clara [1 ,2 ,3 ]
Durand, Jean-Philippe [1 ,2 ,3 ,6 ]
Boudou-Rouquette, Pascaline [1 ,2 ,3 ]
Arrondeau, Jennifer [1 ,2 ,3 ]
Tlemsani, Camille [1 ,2 ,3 ]
Fournel, Ludovic [7 ,8 ]
Alifano, Marco [7 ,8 ]
Wislez, Marie [9 ]
Chapron, Jeanne [9 ]
Le Bris, Camille [1 ,2 ,3 ]
Mansuet-Lupo, Audrey [10 ,11 ]
Damotte, Diane [10 ,11 ]
Neveux, Nathalie [5 ,6 ]
De Bandt, Jean-Pascal [5 ,6 ]
Alexandre, Jerome [1 ,2 ,3 ]
Cynober, Luc [5 ,6 ]
Goldwasser, Francois [1 ,2 ,3 ,6 ]
机构
[1] Paris Ctr Teaching Hosp, AP HP, Med Oncol Dept, Paris, France
[2] Canc Res PErsonalized Med CARPEM, Paris, France
[3] Paris Descartes Univ, USPC, Paris, France
[4] Paris Descartes Univ, Inst Cochin, CNRS UMR8104, INSERM U1016, Paris, France
[5] Paris Descartes Univ, Paris Ctr Teaching Hosp, AP HP, Clin Chem,USPC, Paris, France
[6] Paris Descartes Univ, Pharm Fac, USPC, EA PRETRAM 4466, Paris, France
[7] Paris Ctr Teaching Hosp, AP HP, Thorac Surg Dept, Paris, France
[8] Paris Descartes Univ, Paris, France
[9] Paris Descartes Univ, Paris Ctr Teaching Hosp, AP HP, USPC,Pneumol Dept, Paris, France
[10] Paris Ctr Teaching Hosp, AP HP, Pathol Dept, Paris, France
[11] Paris Descartes Univ, Ctr Rech Cordeliers, USPC, INSERM U1138, Paris, France
关键词
Resting energy expenditure; Malnutrition; Prognosis; Survival; Non-small cell lung cancer; RESTING ENERGY-EXPENDITURE; WEIGHT-LOSS; SKELETAL-MUSCLE; DIETARY-INTAKE; CACHEXIA; IMPACT;
D O I
10.1016/j.clnu.2019.08.003
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background & aims: Metastatic non-small cell lung cancer (NSCLC) is the first cause of cancer death worldwide. Increased resting energy expenditure (REE) is frequent among cancer patients and may contribute to cancer cachexia. The aim of this study was to examine the prognostic value of increased REE in metastatic NSCLC patients. Methods: This observational study was conducted between June 2012 and November 2017 in the outpatient unit of the oncology department of Cochin hospital, Paris. Consecutive patients with newly diagnosed stage IV NSCLC underwent measurement of REE by indirect calorimetry before treatment initiation. Uni- and multivariate analysis of overall survival (OS, Cox models) included age, sex, smoking habit, histological subtype, performance status, body mass index, weight loss, albumin and CRP levels and the ratio of measured REE to the REE predicted by the Harris Benedict formula (mREE/pREE). Results: 144 patients were enrolled: mean age 64 years, 63% male, 90% non-squamous carcinoma, including 17% with ALK/EGFR alteration. In univariate analysis, tobacco consumption (p = 0.007), histomolecular subtype (p < 10(-3)), performance status (p = 0.04), weight loss (p < 10(-4)), albumin (p < 10(-4)), CRP (p = 0.001) and mREE/pREE ratio (>vs <= 120%: HR = 2.16, p < 10(-3)) were significant prognostic factors of OS. Median OS were 6.1 and 17.3 months in patients with mREE/pREE ratio > and <= 120%, respectively. In multivariate analysis, histomolecular subtype (non-squamous ALK/EGFR mutated vs squamous carcinoma: HR = 0.25, p = 0.006), weight loss (>vs <= 5%: HR = 1.98, p = 0.004), albumin (>= vs < 35 g/L: HR = 0.56, p = 0.02) and mREE/pREE ratio (> vs <= 120%: HR = 1.90, p = 0.004) were identified as independent prognostic factors. Conclusions: Elevated resting energy expenditure emerges as an independent prognostic factor in metastatic NSCLC. (C) 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
引用
收藏
页码:1893 / 1899
页数:7
相关论文
共 50 条
  • [1] Sex as a Potential Independent Prognostic Factor in Non-Small Cell Lung Cancer Survival
    Ford-Sahibzada, C.
    Dean, M.
    Peters, C.
    Brenner, D.
    Gibson, A.
    D'Silva, A.
    Elegbede, A.
    Tudor, R.
    Bebb, G. D.
    Cheung, W.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S260 - S260
  • [2] Value of prognostic nutritional index in patients with non-small cell lung cancer
    Kabadayi, Feyyaz
    Akbay, Makbule Oezlem
    Akturk, Ulkue Aka
    Ernam, Dilek
    EURASIAN JOURNAL OF PULMONOLOGY, 2023, 25 (02) : 107 - 115
  • [3] Bone marrow hypermetabolism on 18F-FDG PET as a survival prognostic factor in non-small cell lung cancer
    Prévost, S
    Boucher, L
    Larivée, P
    Boileau, R
    Bénard, F
    JOURNAL OF NUCLEAR MEDICINE, 2006, 47 (04) : 559 - 565
  • [4] Dyspnea as a Prognostic Factor in Patients with Non-Small Cell Lung Cancer
    Ban, Wooho
    Lee, Jong Min
    Ha, Jick Hwan
    Yeo, Chang Dong
    Kang, Hyeon Hui
    Rhee, Chin Kook
    Moon, Hwa Sik
    Lee, Sang Haak
    YONSEI MEDICAL JOURNAL, 2016, 57 (05) : 1063 - 1069
  • [5] The ABO Blood Group is an Independent Prognostic Factor in Patients With Resected Non-small Cell Lung Cancer
    Fukumoto, Koichi
    Taniguchi, Tetsuo
    Usami, Noriyasu
    Kawaguchi, Koji
    Fukui, Takayuki
    Ishiguro, Futoshi
    Nakamura, Shota
    Yokoi, Kohei
    JOURNAL OF EPIDEMIOLOGY, 2015, 25 (02) : 110 - 116
  • [6] Prognostic impact of serum transthyretin in patients with non-small cell lung cancer
    Shimura, Tatsuo
    Shibata, Masahiko
    Inoue, Takuya
    Owada-Ozaki, Yuki
    Yamaura, Takumi
    Muto, Satoshi
    Hasegawa, Takeo
    Shio, Yutaka
    Suzuki, Hiroyuki
    MOLECULAR AND CLINICAL ONCOLOGY, 2019, 10 (06) : 597 - 604
  • [7] Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer
    Sjoblom, Bjorg
    Gronberg, Bjorn H.
    Wentzel-Larsen, Tore
    Baracos, Vickie E.
    Hjermstad, Marianne J.
    Aass, Nina
    Bremnes, Roy M.
    Flotten, Oystein
    Bye, Asta
    Jordhoy, Marit
    CLINICAL NUTRITION, 2016, 35 (06) : 1386 - 1393
  • [8] ATPase inhibitory factor 1 expression is an independent prognostic factor in non-small cell lung cancer
    Gao, Yi-Xing
    Chen, Lu
    Hu, Xu-Gang
    Wu, Hai-Bo
    Cui, You-Hong
    Zhang, Xia
    Wang, Yan
    Liu, Xin-Dong
    Bian, Xiu-Wu
    AMERICAN JOURNAL OF CANCER RESEARCH, 2016, 6 (05): : 1141 - 1148
  • [9] Is the prognostic nutritional index a prognostic and predictive factor in metastatic non-small cell lung cancer patients treated with first-line chemotherapy?
    Bozkaya, Yakup
    Kostek, Osman
    Sakin, Abdullah
    Ozyukseler, Deniz Tataroglu
    Sakalar, Teoman
    Cil, Ibrahim
    SUPPORTIVE CARE IN CANCER, 2020, 28 (05) : 2273 - 2282
  • [10] Pre-treatment hemoglobin levels are an independent prognostic factor in patients with non-small cell lung cancer
    Zhang, Yue-Hua
    Lu, Yuquan
    Lu, Hong
    Zhang, Meng-Wei
    Zhou, Yue-Min
    Li, Xiang-Lei
    Lv, Pin
    Zhao, Xiao-Yan
    MOLECULAR AND CLINICAL ONCOLOGY, 2018, 9 (01) : 44 - 49